<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288643/" ref="ordinalpos=671&amp;ncbi_uid=7054229&amp;link_uid=PMC4288643" image-link="/pmc/articles/PMC4288643/figure/Fig6/" class="imagepopup">Figure 6.  From: Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody"> <b>Schematic summary of the inhibition mechanisms of ZJW on the PI3K/Akt/NF-κB signaling pathway.</b> Activation of PI3K/Akt/NF-κB pathway could reduce MDR phenotype. ZJW suppress phosphorylation of Akt (Ser473) and NF-κB.</div></div>